rethinkTHC Search
Menu
Study breakdown

Cannabinoid Hyperemesis Syndrome in Pregnancy: A Difficult Diagnostic and Treatment Challenge

evidence
The takeaway

CHS during pregnancy poses unique diagnostic and therapeutic challenges due to overlapping symptoms with pregnancy-related conditions and limited safe treatment options.

Obstetricians, maternal-fetal medicine specialists, and emergency physicians managing pregnant patients.

Diagnostic dilemma

CHS symptoms overlap with hyperemesis gravidarum and other pregnancy conditions, leading to delayed diagnosis

What the researchers found

CHS in pregnancy is frequently misdiagnosed due to symptom overlap with hyperemesis gravidarum and other pregnancy complications, compounded by reduced clinician awareness and scarcity of pregnancy-safe treatments.

Why it matters

Prenatal cannabis use is common and associated with adverse outcomes. Adding CHS to the picture creates a complex clinical scenario requiring specialized awareness.

The numbers in context

Not quantified in abstract; clinical perspective reviewing current literature on CHS in pregnancy.

How the study worked

Clinical perspective article reviewing current literature on CHS diagnosis, treatment, and management challenges in pregnancy.

Who was studied

Pregnant women with chronic cannabis use who develop CHS.

What this study cannot tell us

Clinical perspective rather than systematic review. Limited primary evidence available. Treatment recommendations based on expert opinion.

How to read the evidence

Clinical perspective with literature review; expert opinion-level evidence.

When this study was published

Recent clinical perspective reflecting growing awareness of CHS in pregnancy.

The bigger picture

As cannabis use during pregnancy increases with legalization, CHS may become a more common pregnancy complication that obstetricians must be prepared to recognize and manage.

Replication

Clinical perspective; primary research on CHS in pregnancy needed.

Funding

Not specified in abstract

Conflicts of interest

Not specified in abstract

Questions still open

  • How can CHS be reliably distinguished from hyperemesis gravidarum?
  • What treatments are safe and effective for CHS during pregnancy?

Read the original research

Cannabinoid hyperemesis syndrome in pregnancy: Challenges and opportunities.

The Australian & New Zealand journal of obstetrics & gynaecology, 63(6), 746-752

Citation

Kirby, Jordan; Naren, Thileepan. (2023). Cannabinoid hyperemesis syndrome in pregnancy: Challenges and opportunities.. The Australian & New Zealand journal of obstetrics & gynaecology, 63(6), 746-752. https://doi.org/10.1111/ajo.13714